14.777 articles found

[Abeta, tau and alpha-synuclein and glial cells].

Akiyama H.

Nihon Shinkei Seishin Yakurigaku Zasshi · 2006-02-01

PMID: 16637593

Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.

Kozikowski AP, Gaisina IN, Petukhov PA, Sridhar J, King LT, Blond SY, Duka T, Rusnak M, Sidhu A.

ChemMedChem · 2006-02-01

DOI: 10.1002/cmdc.200500039PMID: 16892358

Temperature-induced reversible conformational change in the first 100 residues of alpha-synuclein.

McNulty BC, Tripathy A, Young GB, Charlton LM, Orans J, Pielak GJ.

Protein Sci · 2006-02-01

DOI: 10.1110/ps.051867106PMID: 16452621

Binding of alpha-synuclein affects the lipid packing in bilayers of small vesicles.

Kamp F, Beyer K.

J Biol Chem · 2006-02-01

DOI: 10.1074/jbc.m512292200PMID: 16455667

Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.

Hayashita-Kinoh H, Yamada M, Yokota T, Mizuno Y, Mochizuki H.

Biochem Biophys Res Commun · 2006-01-25

DOI: 10.1016/j.bbrc.2006.01.057PMID: 16460685

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.

Betarbet R, Canet-Aviles RM, Sherer TB, Mastroberardino PG, McLendon C, Kim JH, Lund S, Na HM, Taylor G, Bence NF, Kopito R, Seo BB, Yagi T, Yagi A, Klinefelter G, Cookson MR, Greenamyre JT.

Neurobiol Dis · 2006-01-24

DOI: 10.1016/j.nbd.2005.12.003PMID: 16439141

Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression.

Lauwers E, Bequé D, Van Laere K, Nuyts J, Bormans G, Mortelmans L, Casteels C, Vercammen L, Bockstael O, Nuttin B, Debyser Z, Baekelandt V.

Neurobiol Aging · 2006-01-19

DOI: 10.1016/j.neurobiolaging.2005.12.005PMID: 16423428

Reliability of self-reported ancestry among siblings: implications for genetic association studies.

Burnett MS, Strain KJ, Lesnick TG, de Andrade M, Rocca WA, Maraganore DM.

Am J Epidemiol · 2006-01-18

DOI: 10.1093/aje/kwj057PMID: 16421243

The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy.

Gerard M, Debyser Z, Desender L, Kahle PJ, Baert J, Baekelandt V, Engelborghs Y.

FASEB J · 2006-01-12

DOI: 10.1096/fj.05-5126fjePMID: 16410343

LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

Taylor JP, Mata IF, Farrer MJ.

Trends Mol Med · 2006-01-10

DOI: 10.1016/j.molmed.2005.12.004PMID: 16406842

Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.

Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A.

Neurochem Int · 2006-01-06

DOI: 10.1016/j.neuint.2005.11.008PMID: 16406146

#alpha#--Synuclein aggregation and Parkinson's disease： Factors affecting the aggregation of #alpha#--Synuclein

Jin Ling, Yang Hui.

Sheng wu hua xue yu sheng wu wu li jin zhan · 2006-01-01